Intestinal permeation enhancers for oral peptide delivery
Files in This Item:
|Maher_et_al_2016_ADDR_researchgate.pdf||1.88 MB||Adobe PDF||Download|
|Title:||Intestinal permeation enhancers for oral peptide delivery||Authors:||Maher, Sam
Mrsny, Randall J.
Brayden, David James
|Permanent link:||http://hdl.handle.net/10197/7800||Date:||15-Nov-2016||Abstract:||Intestinal permeation enhancers (PEs) are one of the most widely tested strategies to improve oral delivery of therapeutic peptides. This article assesses the intestinal permeation enhancement action of over 250 PEs that have been tested in intestinal delivery models. In depth analysis of pre-clinical data is presented for PEs as components of proprietary delivery systems that have progressed to clinical trials. Given the importance of co-presentation of sufficiently high concentrations of PE and peptide at the small intestinal epithelium, there is an emphasis on studies where PEs have been formulated with poorly permeable molecules in solid dosage forms and lipoidal dispersions.||Funding Details:||European Commission - Seventh Framework Programme (FP7)
Science Foundation Ireland
|Type of material:||Journal Article||Publisher:||Elsevier||Copyright (published version):||2016 Elsevier||Keywords:||Oral peptide delivery;Intestinal permeation enhancers;Paracellular transport;Transcellular;Solid dose formulation;Surfactants;Emulsions||DOI:||10.1016/j.addr.2016.06.005||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Veterinary Medicine Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.